Phathom Pharmaceuticals launched its first broadcast direct-to-consumer (DTC) campaign to promote Voquezna, its treatment for all severities of erosive gastroesophageal reflux disease (GERD), ...

This retrospective study shows that among nearly 160,000 patients with pulmonary hypertension (PH), those who also had gastroesophageal reflux disease (GERD) had lower rates of morbidity and mortality ...

The FDA approved vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal reflux disease (GERD) in adults. GERD is a condition in which acidic stomach ...

This pharmaceutical composition, dosage form, and treatment method patent is part of a comprehensive IP portfolio covering naronapride, Renexxion's lead compound and a potential best-in-class, orally ...

Phathom Pharmaceuticals (PHAT) is a good biotech to keep an eye on in the coming months because it is gearing up to potentially receive an expanded FDA approval of its drug Voquenza as a daily ...

Most people have experienced heartburn at one time or another, often after a heavy meal. But for some people, that burning pain in the chest can be a frequent occurrence. Gastroesophageal reflux ...

telemedicine Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD. The risk for symptom exacerbation reduced after PPI treatment for patients with GERD ...

Medically reviewed by Daniel More, MD Key Takeaways GERD can worsen asthma symptoms, especially at night.Avoiding certain foods and not lying down after eating can help manage GERD.If GERD treatments ...

Oz Health Is your heartburn triggered by food, stress, or something else entirely? In this video, Dr. Oz teams up with ...